462 related articles for article (PubMed ID: 2904359)
1. Attenuation of anterior pituitary phosphoinositide phosphorylase activity by the D2 dopamine receptor.
Jarvis WD; Judd AM; MacLeod RM
Endocrinology; 1988 Dec; 123(6):2793-9. PubMed ID: 2904359
[TBL] [Abstract][Full Text] [Related]
2. Effect of 17 beta-estradiol on phosphoinositide metabolism and prolactin secretion in anterior pituitary cells.
Kubota T; Kuan SI; MacLeod RM
Neuroendocrinology; 1989 Oct; 50(4):400-5. PubMed ID: 2554176
[TBL] [Abstract][Full Text] [Related]
3. Dopamine does not attenuate phosphoinositide hydrolysis in rat anterior pituitary cells.
Canonico PL; Jarvis WD; Judd AM; MacLeod RM
J Endocrinol; 1986 Sep; 110(3):389-93. PubMed ID: 3020141
[TBL] [Abstract][Full Text] [Related]
4. D-2 dopamine receptor activation reduces free [3H]arachidonate release induced by hypophysiotropic peptides in anterior pituitary cells.
Canonico PL
Endocrinology; 1989 Sep; 125(3):1180-6. PubMed ID: 2527149
[TBL] [Abstract][Full Text] [Related]
5. An islet activating protein-sensitive G protein is involved in dopamine inhibition of angiotensin and thyrotropin-releasing hormone-stimulated inositol phosphate production in anterior pituitary cells.
Journot L; Homburger V; Pantaloni C; Priam M; Bockaert J; Enjalbert A
J Biol Chem; 1987 Nov; 262(31):15106-10. PubMed ID: 3117793
[TBL] [Abstract][Full Text] [Related]
6. The inhibition of phosphatidylinositol turnover: a possible postreceptor mechanism for the prolactin secretion-inhibiting effect of dopamine.
Canonico PL; Valdenegro CA; MacLeod RM
Endocrinology; 1983 Jul; 113(1):7-14. PubMed ID: 6861715
[TBL] [Abstract][Full Text] [Related]
7. Sodium ions: their role and mechanism of action in the control of prolactin release.
Collu R; Lafond J; Marchisio AM; Eljarmak D; Ducharme JR
Endocrinology; 1984 Apr; 114(4):1302-7. PubMed ID: 6423371
[TBL] [Abstract][Full Text] [Related]
8. Differential regulation by phosphatidylinositol 4,5-bisphosphate of pituitary plasma-membrane and cytosolic phosphoinositide kinases.
Imai A; Rebecchi MJ; Gershengorn MC
Biochem J; 1986 Dec; 240(2):341-8. PubMed ID: 3028374
[TBL] [Abstract][Full Text] [Related]
9. The dynamics of arachidonic acid liberation and prolactin release: a comparison of thyrotropin-releasing hormone, angiotensin II, and neurotensin stimulation in perifused rat anterior pituitary cells.
Ross PC; Judd AM; MacLeod RM
Endocrinology; 1988 Nov; 123(5):2445-53. PubMed ID: 3139397
[TBL] [Abstract][Full Text] [Related]
10. Effects of thyrotropin-releasing hormone on phosphoinositides and cytoplasmic free calcium in thyrotropic pituitary cells.
Brenner-Gati L; Gershengorn MC
Endocrinology; 1986 Jan; 118(1):163-9. PubMed ID: 3000732
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of inositol phosphate production is a late, Ca2+-dependent effect of D2 dopaminergic receptor activation in rat lactotroph cells.
Vallar L; Vicentini LM; Meldolesi J
J Biol Chem; 1988 Jul; 263(21):10127-34. PubMed ID: 2839476
[TBL] [Abstract][Full Text] [Related]
12. Neurotensin stimulates polyphosphoinositide breakdown and prolactin release in anterior pituitary cells in culture.
Canonico PL; Sortino MA; Speciale C; Scapagnini U
Mol Cell Endocrinol; 1985 Oct; 42(3):215-20. PubMed ID: 2995163
[TBL] [Abstract][Full Text] [Related]
13. Dopamine receptors on intact anterior pituitary cells in culture: functional association with the inhibition of prolactin and thyrotropin.
Foord SM; Peters JR; Dieguez C; Scanlon MF; Hall R
Endocrinology; 1983 May; 112(5):1567-77. PubMed ID: 6832061
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin peptides stimulate phosphoinositide breakdown and prolactin release in anterior pituitary cells in culture.
Canonico PL; MacLeod RM
Endocrinology; 1986 Jan; 118(1):233-8. PubMed ID: 3000736
[TBL] [Abstract][Full Text] [Related]
15. Ca2+ ionophores affect phosphoinositide metabolism differently than thyrotropin-releasing hormone in GH3 pituitary cells.
Kolesnick RN; Gershengorn MC
J Biol Chem; 1984 Aug; 259(15):9514-9. PubMed ID: 6086636
[TBL] [Abstract][Full Text] [Related]
16. Phosphatidylinositol 4,5-bisphosphate turnover is transient while phosphatidylinositol turnover is persistent in thyrotropin-releasing hormone-stimulated rat pituitary cells.
Imai A; Gershengorn MC
Proc Natl Acad Sci U S A; 1986 Nov; 83(22):8540-4. PubMed ID: 3022295
[TBL] [Abstract][Full Text] [Related]
17. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
Ishibashi M; Yamaji T
J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
[TBL] [Abstract][Full Text] [Related]
18. Calcitonin decreases thyrotropin-releasing hormone-stimulated prolactin release through a mechanism that involves inhibition of inositol phosphate production.
Judd AM; Kubota T; Kuan SI; Jarvis WD; Spangelo BL; Macleod RM
Endocrinology; 1990 Jul; 127(1):191-9. PubMed ID: 2163310
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic evidence that a D2 receptor subtype mediates dopaminergic stimulation of prolactin secretion from the anterior pituitary gland.
Burris TP; Stringer LC; Freeman ME
Neuroendocrinology; 1991 Aug; 54(2):175-83. PubMed ID: 1685014
[TBL] [Abstract][Full Text] [Related]
20. Lipid products of phosphoinositide 3-kinase bind human profilin with high affinity.
Lu PJ; Shieh WR; Rhee SG; Yin HL; Chen CS
Biochemistry; 1996 Nov; 35(44):14027-34. PubMed ID: 8909300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
